SUBSEQUENT EVENTS (Details Narrative) - USD ($)	Oct. 25, 2024	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Oct. 05, 2017
Subsequent Event [Line Items]
Common stock, shares authorized		300,000,000	300,000,000
Common stock, par value		$ 0.001	$ 0.001	$ 0.001
Preferred stock, shares authorized		50,000,000	50,000,000
Preferred stock, par value		$ 0.001	$ 0.001	$ 0.001
Common stock, shares outstanding		82,238,648	145,642,333
Subsequent Event [Member]
Subsequent Event [Line Items]
Common stock, shares authorized	3,389,169
Common stock, par value	$ 0.109
Preferred stock, shares authorized	28,467,564
Preferred stock, par value	$ 0.543
Book value	$ 11,842,428
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 8,190,000
NDPD Pharma Inc [Member]
Subsequent Event [Line Items]
Acquisition of shares	14,085,410
Common stock, shares authorized					95,000,000
Common stock, par value					$ 0.0001
Preferred stock, shares authorized					5,000,000
Preferred stock, par value					$ 0.0001
Fair market value	$ 7,660,000
Book value	$ 4,007,572
Royalty percentage	33.00%
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 8,190,000
NDPD Pharma Inc [Member] | Stock Purchase Agreement [Member] | Non Affiliates [Member]
Subsequent Event [Line Items]
Acquisition of shares	3,389,169
NDPD Pharma Inc [Member] | Stock Purchase Agreement [Member] | Affiliates [Member]
Subsequent Event [Line Items]
Acquisition of shares	28,467,564
NDPD Pharma Inc [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Issued and outstanding shares of common stock	100.00%
Common stock, shares outstanding	15,000,000
NDPD Pharma Inc [Member] | Subsequent Event [Member] | Stock Purchase Agreement [Member]
Subsequent Event [Line Items]
Issued and outstanding shares of common stock	100.00%